{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T02:23:12Z","timestamp":1792030992815,"version":"4.4.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2016,5,23]],"date-time":"2016-05-23T00:00:00Z","timestamp":1463961600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00105-016-3806-2","type":"journal-article","created":{"date-parts":[[2016,5,24]],"date-time":"2016-05-24T05:35:01Z","timestamp":1464068101000},"page":"454-463","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Psoriasis in besonderen Lokalisationen","Psoriasis in special localizations"],"prefix":"10.1007","volume":"67","author":[{"given":"A.","family":"Schmieder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. K.","family":"Peitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,23]]},"reference":[{"key":"3806_CR1","first-page":"667","volume":"12","author":"M Augustin","year":"2014","unstructured":"Augustin M, Mrowietz U, Bonnekoh B et al (2014) Topical long-term therapy of psoriasis with vitamin D(3) analogues, corticosteroids and their two compound formulations: position paper on evidence and use in daily practice. J Dtsch Dermatol Ges 12:667\u2013682","journal-title":"J Dtsch Dermatol Ges"},{"key":"3806_CR2","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.1365-2133.2010.09831.x","volume":"163","author":"M Augustin","year":"2010","unstructured":"Augustin M, Reich K, Blome C et\u00a0al (2010) Nail psoriasis in Germany: epidemiology and burden of disease. Br J Dermatol 163:580\u2013585","journal-title":"Br J Dermatol"},{"key":"3806_CR3","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jaad.2011.07.034","volume":"67","author":"J Bagel","year":"2012","unstructured":"Bagel J, Lynde C, Tyring S et al (2012) Moderate to severe plaque psoriasis with scalp involvement: a randomized, double-blind, placebo-controlled study of etanercept. J Am Acad Dermatol 67:86\u201392","journal-title":"J Am Acad Dermatol"},{"key":"3806_CR4","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/j.jaad.2008.11.890","volume":"60","author":"CS Chan","year":"2009","unstructured":"Chan CS, Van Voorhees AS, Lebwohl MG et\u00a0al (2009) Treatment of severe scalp psoriasis: from the Medical Board of the National Psoriasis Foundation. J\u00a0Am Acad Dermatol 60:962\u2013971","journal-title":"J Am Acad Dermatol"},{"key":"3806_CR5","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1468-3083.2012.04642.x","volume":"27","author":"C Simone De","year":"2013","unstructured":"Simone C De, Maiorino A, Tassone F et al (2013) Tacrolimus 0.1\u202f% ointment in nail psoriasis: a randomized controlled open-label study. J Eur Acad Dermatol Venereol 27:1003\u20131006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3806_CR6","first-page":"CD007633","volume":"1","author":"AC Vries De","year":"2013","unstructured":"Vries AC De, Bogaards NA, Hooft L et\u00a0al (2013) Interventions for nail psoriasis. Cochrane Database Syst Rev 1:CD007633","journal-title":"Cochrane Database Syst Rev"},{"key":"3806_CR7","first-page":"1858","volume":"120","author":"LK Dotterud","year":"2000","unstructured":"Dotterud LK, Braun R (2000) UV-B comb versus betamethasone solution in scalp psoriasis. Tidsskr Nor Laegeforen 120:1858\u20131859","journal-title":"Tidsskr Nor Laegeforen"},{"key":"3806_CR8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/00015550310007463","volume":"83","author":"I Flytstrom","year":"2003","unstructured":"Flytstrom I, Bergbrant IM, Brared J et\u00a0al (2003) Microorganisms in intertriginous psoriasis: no evidence of Candida. Acta Derm Venereol 83:121\u2013123","journal-title":"Acta Derm Venereol"},{"key":"3806_CR9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1468-3083.2008.02942.x","volume":"23","author":"S Gattu","year":"2009","unstructured":"Gattu S, Rashid RM, Wu JJ (2009) 308-nm excimer laser in psoriasis vulgaris, scalp psoriasis, and palmoplantar psoriasis. J Eur Acad Dermatol Venereol 23:36\u201341","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3806_CR10","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1468-3083.2010.03927.x","volume":"25","author":"M Gumusel","year":"2011","unstructured":"Gumusel M, Ozdemir M, Mevlitoglu I et al (2011) Evaluation of the efficacy of methotrexate and cyclosporine therapies on psoriatic nails: a one-blind, randomized study. J Eur Acad Dermatol Venereol 25:1080\u20131084","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3806_CR11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jaad.2008.04.027","volume":"59","author":"GB Jemec","year":"2008","unstructured":"Jemec GB, Ganslandt C, Ortonne JP et al (2008) A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial. J Am Acad Dermatol 59:455\u2013463","journal-title":"J Am Acad Dermatol"},{"key":"3806_CR12","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/art.24403","volume":"60","author":"A Kavanaugh","year":"2009","unstructured":"Kavanaugh A, Mcinnes I, Mease P et al (2009) Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebo-controlled study. Arthritis Rheum 60:976\u2013986","journal-title":"Arthritis Rheum"},{"key":"3806_CR13","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3109\/09546634.2012.681017","volume":"24","author":"K Kragballe","year":"2013","unstructured":"Kragballe K, Menter A, Lebwohl M et al (2013) Long-term management of scalp psoriasis: perspectives from the International Psoriasis Council. J Dermatolog Treat 24:188\u2013192","journal-title":"J Dermatolog Treat"},{"key":"3806_CR14","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1111\/jdv.12996","volume":"29","author":"RG Langley","year":"2015","unstructured":"Langley RG, Rich P, Menter A et\u00a0al (2015) Improvement of scalp and nail lesions with ixekizumab in a phase 2 trial in patients with chronic plaque psoriasis. J\u00a0Eur Acad Dermatol Venereol 29:1763\u20131770","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3806_CR15","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.jaad.2004.07.011","volume":"51","author":"M Lebwohl","year":"2004","unstructured":"Lebwohl M, Freeman AK, Chapman MS et\u00a0al (2004) Tacrolimus ointment is effective for facial and intertriginous psoriasis. J\u00a0Am Acad Dermatol 51:723\u2013730","journal-title":"J Am Acad Dermatol"},{"key":"3806_CR16","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1001\/archdermatol.2010.384","volume":"147","author":"C Leonardi","year":"2011","unstructured":"Leonardi C, Langley RG, Papp K et al (2011) Adalimumab for treatment of moderate to severe chronic plaque psoriasis of the hands and feet: efficacy and safety results from REACH, a randomized, placebo-controlled, double-blind trial. Arch Dermatol 147:429\u2013436","journal-title":"Arch Dermatol"},{"key":"3806_CR17","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1365-2133.2007.08201.x","volume":"157","author":"YH Liao","year":"2007","unstructured":"Liao YH, Chiu HC, Tseng YS et\u00a0al (2007) Comparison of cutaneous tolerance and efficacy of calcitriol 3 microg g-1 ointment and tacrolimus 0.3\u202fmg g-1 ointment in chronic plaque psoriasis involving facial or genitofemoral areas: a double-blind, randomized controlled trial. Br J Dermatol 157:1005\u20131012","journal-title":"Br J Dermatol"},{"key":"3806_CR18","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1111\/j.1468-3083.2009.03211.x","volume":"23","author":"TA Luger","year":"2009","unstructured":"Luger TA, Barker J, Lambert J et al (2009) Sustained improvement in joint pain and nail symptoms with etanercept therapy in patients with moderate-to-severe psoriasis. J Eur Acad Dermatol Venereol 23:896\u2013904","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"Suppl 2","key":"3806_CR19","first-page":"AB120","volume":"58","author":"A Menter","year":"2008","unstructured":"Menter A, Reich K, Li S, Guzzo C (2008) Consistency of infliximab response in different body regions for treatment of moderate to severe psoriasis: results from controlled clinical tria. J\u00a0Am Acad Dermatol 58(Suppl 2):AB120","journal-title":"J Am Acad Dermatol"},{"key":"3806_CR20","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1111\/j.1468-3083.2009.03372.x","volume":"23","author":"J Ortonne","year":"2009","unstructured":"Ortonne J, Chimenti S, Luger T et\u00a0al (2009) Scalp psoriasis: European consensus on grading and treatment algorithm. J\u00a0Eur Acad Dermatol Venereol 23:1435\u20131444","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3806_CR21","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/bjd.12060","volume":"168","author":"JP Ortonne","year":"2013","unstructured":"Ortonne JP, Paul C, Berardesca E et al (2013) A 24-week randomized clinical trial investigating the efficacy and safety of two doses of etanercept in nail psoriasis. Br J Dermatol 168:1080\u20131087","journal-title":"Br J Dermatol"},{"key":"3806_CR22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3109\/09546630903493311","volume":"21","author":"Y Poulin","year":"2010","unstructured":"Poulin Y, Papp K, Bissonnette R et al (2010) Clobetasol propionate shampoo 0.05\u202f% is efficacious and safe for long-term control of moderate scalp psoriasis. J Dermatolog Treat 21:185\u2013192","journal-title":"J Dermatolog Treat"},{"key":"3806_CR23","first-page":"203","volume":"11","author":"MA Radtke","year":"2013","unstructured":"Radtke MA, Beikert FC, Augustin M (2013) Nail psoriasis \u2013 a treatment challenge. J\u00a0Dtsch Dermatol Ges 11:203\u2013219 (quiz 220)","journal-title":"J Dtsch Dermatol Ges"},{"key":"3806_CR24","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1056\/NEJMoa1010858","volume":"365","author":"K Reich","year":"2011","unstructured":"Reich K, Langley RG, Papp KA et al (2011) A 52-week trial comparing briakinumab with methotrexate in patients with psoriasis. N Engl J Med 365:1586\u20131596","journal-title":"N Engl J Med"},{"key":"3806_CR25","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000317775","volume":"221","author":"K Reich","year":"2010","unstructured":"Reich K, Ortonne JP, Kerkmann U et al (2010) Skin and nail responses after 1 year of infliximab therapy in patients with moderate-to-severe psoriasis: a retrospective analysis of the EXPRESS Trial. Dermatology 221:172\u2013178","journal-title":"Dermatology"},{"key":"3806_CR26","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/bjd.12632","volume":"170","author":"P Rich","year":"2014","unstructured":"Rich P, Bourcier M, Sofen H et al (2014) Ustekinumab improves nail disease in patients with moderate-to-severe psoriasis: results from PHOENIX 1. Br J Dermatol 170:398\u2013407","journal-title":"Br J Dermatol"},{"key":"3806_CR27","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jaad.2015.09.001","volume":"74","author":"P Rich","year":"2016","unstructured":"Rich P, Gooderham M, Bachelez H et al (2016) Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with difficult-to-treat nail and scalp psoriasis: Results of 2 phase\u00a0III randomized, controlled trials (ESTEEM 1 and ESTEEM 2. J Am Acad Dermatol 74:134\u2013142","journal-title":"J Am Acad Dermatol"},{"key":"3806_CR28","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jaad.2007.07.042","volume":"58","author":"P Rich","year":"2008","unstructured":"Rich P, Griffiths CE, Reich K et\u00a0al (2008) Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year. J\u00a0Am Acad Dermatol 58:224\u2013231","journal-title":"J Am Acad Dermatol"},{"key":"3806_CR29","doi-asserted-by":"crossref","first-page":"167","DOI":"10.2340\/00015555-0195","volume":"87","author":"D Rigopoulos","year":"2007","unstructured":"Rigopoulos D, Gregoriou S, Katsambas A (2007) Treatment of psoriatic nails with tazarotene cream 0.1\u202f% vs. clobetasol propionate 0.05\u202f% cream: a double-blind study. Acta Derm Venereol 87:167\u2013168","journal-title":"Acta Derm Venereol"},{"key":"3806_CR30","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1080\/00015550252948220","volume":"82","author":"D Rigopoulos","year":"2002","unstructured":"Rigopoulos D, Ioannides D, Prastitis N et\u00a0al (2002) Nail psoriasis: a combined treatment using calcipotriol cream and clobetasol propionate cream. Acta Derm Venereol 82:140","journal-title":"Acta Derm Venereol"},{"issue":"Suppl 5","key":"3806_CR31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/jdv.12562","volume":"28","author":"M Rouzaud","year":"2014","unstructured":"Rouzaud M, Sevrain M, Villani AP et\u00a0al (2014) Is there a psoriasis skin phenotype associated with psoriatic arthritis? Systematic literature review. J\u00a0Eur Acad Dermatol Venereol 28(Suppl 5):17\u201326","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3806_CR32","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/j.jaad.2015.02.1127","volume":"72","author":"C Ryan","year":"2015","unstructured":"Ryan C, Sadlier M, Vol E De et\u00a0al (2015) Genital psoriasis is associated with significant impairment in quality of life and sexual functioning. J\u00a0Am Acad Dermatol 72:978\u2013983","journal-title":"J Am Acad Dermatol"},{"key":"3806_CR33","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.ad.2014.02.015","volume":"105","author":"M Sanchez-Regana","year":"2014","unstructured":"Sanchez-Regana M, Aldunce Soto MJ, Belinchon Romero I et al (2014) Evidence-based guidelines of the spanish psoriasis group on the use of biologic therapy in patients with psoriasis in difficult-to-treat sites (nails, scalp, palms, and soles. Actas Dermosifiliogr 105:923\u2013934","journal-title":"Actas Dermosifiliogr"},{"key":"3806_CR34","first-page":"CD009687","volume":"2","author":"JG Schlager","year":"2016","unstructured":"Schlager JG, Rosumeck S, Werner RN et\u00a0al (2016) Topical treatments for scalp psoriasis. Cochrane Database Syst Rev 2:CD009687","journal-title":"Cochrane Database Syst Rev"},{"key":"3806_CR35","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/jdv.12553","volume":"29","author":"D Thaci","year":"2015","unstructured":"Thaci D, Unnebrink K, Sundaram M et\u00a0al (2015) Adalimumab for the treatment of moderate to severe psoriasis: subanalysis of effects on scalp and nails in the BELIEVE study. J\u00a0Eur Acad Dermatol Venereol 29:353\u2013360","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3806_CR36","first-page":"269","volume":"145","author":"A Tosti","year":"2009","unstructured":"Tosti A, Ricotti C, Romanelli P et\u00a0al (2009) Evaluation of the efficacy of acitretin therapy for nail psoriasis. Arch Dermatol 145:269\u2013271","journal-title":"Arch Dermatol"},{"key":"3806_CR37","first-page":"70","volume":"9","author":"G Wozel","year":"2011","unstructured":"Wozel G, Klein E, Mrowietz U et\u00a0al (2011) Scalp psoriasis. J\u00a0Dtsch Dermatol Ges 9:70\u201374","journal-title":"J Dtsch Dermatol Ges"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-016-3806-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-016-3806-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-016-3806-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T03:40:49Z","timestamp":1558582849000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-016-3806-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,23]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["3806"],"URL":"https:\/\/doi.org\/10.1007\/s00105-016-3806-2","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,23]]}}}